Article · 29 Aug 2026
Conference abstract
Rational design of synthetic vaccine particles (SVP) for therapeutic treatment of chronic diseases
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
V accines for the prophylaxis of infectious diseases have been one of the most effective interventions for improving human health. Recent advances in immunology and vaccine technology have opened the door to novel vaccine-based therapies for the therapeutic treatment of chronic diseases. We have developed a flexible and modular Synthetic Vaccine Particle (SVP) technology that enables the rational design of both stimulatory vaccines and tolerogenic immune therapies. Our targeted SVPs (tSVP) have been designed and optimized to promote efficient cross-presentation of antigen and stimulate robust cellular immunity for the treatment of cancer and chronic infections, while our tolerogenic targeted SVPs (t 2 SVP) are designed to induce immune tolerance for the treatment of autoimmune diseases, allergies, and immunogenicity of biological therapies. We will describe the general design principles of these synthetic, self-assembling nanoparticles and provide examples for use in various disease settings.
Keywords
Subjects
Vaccines & ImmunisationAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Vaccines & Vaccination.
Article · 29 Aug 2026
Advances in Adjuvant Development for Enhanced Vaccine Performance and Long-Term Immune Protection
Article · 20 Jun 2026
Herd Immunity and Its Role in Controlling Infectious Diseases
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Vaccines & Vaccination
- SubjectVaccines & Immunisation
- BylineArticles whose byline prints “Takashi Kei Kishimoto”